Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study
About this trial
This trial is enrolling individuals with chronic cervical or thoracic spinal cord injuries to test the effect of skin-surface (transcutaneous) electrical stimulation of the spinal cord. Investigators want to see if a neuromodulation technique called SCONE (Spinal COrd NEuromodulation) improves urinary tract dysfunction. If included, participants will receive SCONE therapy for 12 weeks with either: 1) experimental neuromodulation; or 2) sham (inactive) neuromodulation. Final testing will be performed after 12 weeks.
Included participants
What’s involved
Type
Details
Participants will receive SCONE neuromodulation therapy for 12 weeks with either 1) experimental neuromodulation or 2) Sham neuromodulation. Final testing will be performed after 12 weeks.
Potential benefits
Main benefits
Bladder health/function
Additional benefits
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more- Trial recruitment status
- Recruiting
- Trial start date
- 25 May 2022
- Organisation
- SpineX Inc.
- Trial recruitment status
- Recruiting
- Trial start date
- 25 May 2022
- Organisation
- SpineX Inc.
About this trial
Included participants
What’s involved
Potential benefits
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more